Delivery Order SPE2DB24D8003-SPE2DB25FJUGN
Award Date
4/25/25
Potential Completion Date
4/28/25
Potential Value
$10K
Federal Agency
Defense Logistics Agency
Awardee
Dakota Drug, Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $15,860.63, is for the delivery of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical operations. The contract has an ultimate completion date of March 20, 2025. Dakota Drug, Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued at...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract has a ceiling value of $3,707.66 and a period of performance through February 24, 2025. The contract is for the delivery of pharmaceutical products, including ZEPBOUND 15 MG/0.5 ML PEN 0.5ML, to support U.S. Armed Forces medical operations. Dakota Drug, Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This contract award to Dakota Drug, Inc., a self-certified small disadvantaged business, is a firm fixed-price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical for the supply of pharmaceutical products, including prescription medications such as insulin pens, inhalers, anticoagulants, and biologic drugs. The contract, valued at $11,449.29, has an ultimate completion date of September 4, 2024 and is not designated as a set-aside contract. Dakota Drug, Inc. holds a...
The federal contract award SPE2DB24D8001 to Dakota Drug, Inc., a self-certified small disadvantaged business, provides for the delivery of pharmaceutical products, medical supplies, and healthcare equipment to the U.S. Department of Defense through the Defense Logistics Agency (DLA) Troop Support Medical program. This single-award Indefinite Delivery Contract (IDC), valued at $999,999,999.00, allows Dakota Drug, Inc. to supply a comprehensive range of critical medical items, including treatments...
The U.S. Department of Defense, through the Defense Logistics Agency (DLA) Troop Support Medical division, awarded a Firm Fixed Price delivery order contract valued at $4,787.60 to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of SKYLA 13.5 MG SYSTEMS medical supplies, with a performance period extending through April 25, 2024. This delivery order is part of Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) with the DLA, identified...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract worth $9,456.99 to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of STELARA 90 MG/ML SYRINGEML, a pharmaceutical product, with an ultimate completion date of October 18, 2024. This award is part of Dakota Drug, Inc.'s Indefinite Delivery Contract (IDC) SPE2DB24D8001 valued at $999,999,999.00, which allows the company to provide a comprehensive range of...
This is a delivery order contract (SPE2DB24D8002/SPE2DB25FJNCT) awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the supply of pharmaceutical products, medical supplies, and healthcare equipment. The contract has a ceiling value of $10,364.55 and a completion date of February 10, 2025. Dakota Drug, Inc. is a key supplier for the DLA Troop Support Medical division, holding a $999,999,999.00 Indefinite Delivery Contract (IDC)...
This is a federal contract award to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $3,539.65, is a firm fixed-price delivery order with no set-aside designation. The contract provides for the delivery of pharmaceutical products, including treatments for conditions such as diabetes, asthma, COPD, hypertension, and autoimmune disorders. Specific...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a small disadvantaged business. The contract is for the delivery of Orencia 125 mg/ml syringes, a pharmaceutical product. The contract has a firm fixed price of $7,098.20 and a period of performance extending to March 10, 2025. Dakota Drug, Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, that allows the company to provide a range of...
This is a $11,114.44 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a small disadvantaged business, for the supply of STELARA 90 MG/ML syringes. The contract has an ultimate completion date of May 2, 2024. Dakota Drug, Inc. is a key supplier of pharmaceutical products, medical supplies, and healthcare equipment to the U.S. Department of Defense, with a significant single-award Indefinite Delivery Contract (IDC) with the DLA Troop...